risedronic acid has been researched along with Weight Gain in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, YF | 1 |
| Pan, Z | 1 |
| Jee, WS | 1 |
| Lin, CH | 1 |
| Liang, HH | 1 |
| Chen, H | 1 |
| Pun, S | 1 |
| Li, XJ | 1 |
1 other study available for risedronic acid and Weight Gain
| Article | Year |
|---|---|
Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats.
Topics: Animals; Bone and Bones; Bone Density; Bone Remodeling; Calcium Channel Blockers; Dinoprostone; Drug | 1997 |